跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SANDOZ ADAPALENE / BENZOYL PEROXIDE FORTE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SANDOZ ADAPALENE / BENZOYL PEROXIDE FORTE
Authorized
STANDARD
SANDOZ ADAPALENE / BENZOYL PEROXIDE FORTE
Sandoz Canada, Inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
b28b0e89c292c72b
Company
Sandoz Canada, Inc.
Type
Standard
Approval Details
Approval Id
b28b0e89c292c72b
Drug Approval Canada Name
SANDOZ ADAPALENE / BENZOYL PEROXIDE FORTE
Product Name
SANDOZ ADAPALENE / BENZOYL PEROXIDE FORTE
Status
Marketed
Status Date
2022-01-26
Original Market Date
2022-01-26
Din
02517205
Drug Class
Human
Dosage Form
Gel
Route Of Administration
Topical
Schedule
Prescription
Ahfs
84:92.00
Atc Original
D10AD53 ADAPALENE, COMBINATIONS
Atc Name
d 10 ad 53
Aig Number
0252888002
Company Name
Sandoz Canada, Inc.
Company Address
4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path
/organization/sandoz-canada-inc
Company Information
Pharmaceutical Company Name
Sandoz Canada, Inc.
Country Name
Canada
Website
http://www.sandoz.ca
Active Ingredients
BENZOYL PEROXIDE
2.5 % / W/W
ADAPALENE
0.3 % / W/W
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
b28b0e89c292c72b
Type
Standard
Back to Health Canada Approvals